Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy PolarityTE stock | 0.8338

Own PolarityTE stock in just a few minutes.

Posted

Fact checked

PolarityTE, Inc is a biotechnology business based in the US. PolarityTE shares (PTE) are listed on the NASDAQ and all prices are listed in US Dollars. PolarityTE employs 153 staff and has a trailing 12-month revenue of around USD$8 million.

How to buy shares in PolarityTE

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for PolarityTE. Find the stock by name or ticker symbol: PTE. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until PolarityTE reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$0.8338, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of PolarityTE, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of PolarityTE. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

PolarityTE share price

Use our graph to track the performance of PTE stocks over time.

PolarityTE shares at a glance

Information last updated 2020-11-20.
Latest market close USD$0.8338
52-week range USD$0.72 - USD$4.6
50-day moving average USD$0.9803
200-day moving average USD$1.1651
Wall St. target price USD$3
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-4.842

Buy PolarityTE shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy PolarityTE stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PolarityTE price performance over time

Historical closes compared with the close of $0.8338 from 2020-11-16

1 week (2020-11-16) 0.8338
1 month (2020-10-23) -16.58%
3 months (2020-08-24) -34.86%
6 months (2020-05-22) -6.30%
1 year (2019-11-22) -73.19%
2 years (2018-11-23) -94.40%
3 years (2017-11-24) -96.66%
5 years (2015-11-24) -26.14%

PolarityTE financials

Revenue TTM USD$8 million
Gross profit TTM USD$3.2 million
Return on assets TTM -56.09%
Return on equity TTM -140.2%
Profit margin 0%
Book value $0.701
Market capitalisation USD$38 million

TTM: trailing 12 months

Shorting PolarityTE shares

There are currently 2.4 million PolarityTE shares held short by investors – that's known as PolarityTE's "short interest". This figure is 7.7% down from 2.6 million last month.

There are a few different ways that this level of interest in shorting PolarityTE shares can be evaluated.

PolarityTE's "short interest ratio" (SIR)

PolarityTE's "short interest ratio" (SIR) is the quantity of PolarityTE shares currently shorted divided by the average quantity of PolarityTE shares traded daily (recently around 593272.16748768). PolarityTE's SIR currently stands at 4.06. In other words for every 100,000 PolarityTE shares traded daily on the market, roughly 4060 shares are currently held short.

However PolarityTE's short interest can also be evaluated against the total number of PolarityTE shares, or, against the total number of tradable PolarityTE shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PolarityTE's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 PolarityTE shares in existence, roughly 60 shares are currently held short) or 0.081% of the tradable shares (for every 100,000 tradable PolarityTE shares, roughly 81 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PolarityTE.

Find out more about how you can short PolarityTE stock.

PolarityTE share dividends

We're not expecting PolarityTE to pay a dividend over the next 12 months.

Have PolarityTE's shares ever split?

PolarityTE's shares were split on a 1:6 basis on 1 August 2016. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PolarityTE shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for PolarityTE shares which in turn could have impacted PolarityTE's share price.

PolarityTE share price volatility

Over the last 12 months, PolarityTE's shares have ranged in value from as little as $0.72 up to $4.6. A popular way to gauge a stock's volatility is its "beta".

PTE.US volatility(beta: 1.71)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PolarityTE's is 1.7097. This would suggest that PolarityTE's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

PolarityTE overview

PolarityTE, Inc., a biotechnology and regenerative biomaterials company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site